# Hemodialysis Peritoneal Dialysis Market > Hemodialysis and Peritoneal Dialysis Market Research Report By Procedure (Hemodialysis, Peritoneal Dialysis), By Product Type (Dialysis Machines, Dialysis Consumables, Dialysis Accessories), By Application (End-Stage Renal Disease, Acute Renal Failure, Chronic Kidney Disease), By End User (Hospitals, Dialysis Centers, Home Healthcare), By Modality (In-Center Hemodialysis, Home Hemodialysis, Continuous Renal Replacement Therapy (CRRT)) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.92% - **2024:** $ 113.13 Billion - **2025:** $ 119.83 Billion - **2035:** $ 212.98 Billion - **Key Players:** Fresenius Medical Care (DE), DaVita Inc. (US), Baxter International Inc. (US), Nipro Corporation (JP), Medtronicplc (IE), Asahi Kasei Corporation (JP), Kawasumi Laboratories, Inc. (JP), Dialysis Clinic, Inc. (US), Renal Care Group (US) **Report ID:** MRFR/HC/22744-HCR · **Pages:** 128 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** April 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/hemodialysis-peritoneal-dialysis-market-24365 --- ## Market Summary ## **Global Hemodialysis and Peritoneal Dialysis Market Overview** As per MRFR analysis, the Hemodialysis and Peritoneal Dialysis Market Size was estimated at 113.13 (USD Billion) in 2024. The Hemodialysis and Peritoneal Dialysis Market Industry is expected to grow from 119.83 (USD Billion) in 2025 to 201.08 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 5.92% during the forecast period (2025 - 2034). ### **Key Hemodialysis and Peritoneal Dialysis Market Trends Highlighted** The Hemodialysis and Peritoneal Dialysis Market is experiencing significant growth due to the rising prevalence of chronic kidney disease and the increasing aging population. Technological advancements, such as automated peritoneal dialysis and wearable hemodialysis devices, are improving patient outcomes and convenience. The demand for home-based dialysis is also growing, as it offers patients greater flexibility and control over their treatment. Moreover, the increasing adoption of telemedicine in dialysis care is enhancing accessibility and reducing the burden on healthcare systems. The market is also driven by the growing awareness of kidney health and the availability of government initiatives to support dialysis patients. Additionally, collaborations between medical device manufacturers and healthcare providers are fostering innovation and improving the quality of dialysis care. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ## **Hemodialysis and Peritoneal Dialysis Market Drivers** Growing Prevalence of Chronic Kidney Disease Chronic kidney disease (CKD) is a major public health concern, affecting millions of people worldwide. CKD is characterized by a gradual loss of kidney function, which can lead to end-stage renal disease (ESRD). ESRD requires dialysis or a kidney transplant to survive. Hemodialysis and Peritoneal Dialysis are two common types of dialysis that are used to treat ESRD. As the prevalence of CKD continues to rise, so will the demand for Hemodialysis and Peritoneal Dialysis services. The rising prevalence of CKD is primarily driven by the increasing prevalence of risk factors such as diabetes, hypertension, and obesity. Diabetes is a major cause of CKD, as it can damage the blood vessels in the kidneys. Hypertension, or high blood pressure, can also damage the kidneys over time. Obesity is another risk factor for CKD, as it can lead to inflammation and scarring of the kidneys. The growing prevalence of CKD is a major challenge for healthcare systems around the world. Hemodialysis and Peritoneal Dialysis are essential treatments for ESRD, but they are also expensive and time-consuming. As the number of ESRD patients continues to grow, so too will the demand for these treatments. This is expected to drive significant growth in the Hemodialysis and Peritoneal Dialysis Market in the coming years. Technological Advancements in Dialysis Equipment Technological progress is reflected in ongoing improvement of the Hemodialysis and Peritoneal Dialysis treatments both in terms of their safety and efficacy. New-generation dialysis machines are equipped with better options, making their use more versatile and easier. There appear to be novel dialysis machines capable of conducting so-called nocturnal dialysis. It is the type of dialysis conducted at night during the period of one's sleep. It is less disturbing for the patient, as it does not interfere with his normal lifestyle, but it also becomes more convenient due to the use of the novel dialysis machines. In addition, new dialyzers have been developed. They are crucial gadgets, being a kind of a filter removing waste products from the blood. The newly designed dialyzers are more efficient than the previous ones and are more durable resulting in less costs. There are also being developed technologies facilitating peritoneal dialysis. This type of dialysis is conducted at home by the patient. Novel technologies imply the use of a cycler machine capable of conducting dialysis automatically. In such a way, the patient is relieved from the need to conduct dialysis exchanges on his or her own. Increasing Demand for Home Dialysis Home dialysis is a growing trend in the Hemodialysis and Peritoneal Dialysis Market. Home dialysis allows patients to receive dialysis treatments in the comfort of their own homes, which can be more convenient and less stressful than attending a dialysis center. There are two main types of home dialysis: peritoneal dialysis and home hemodialysis. Peritoneal dialysis is a type of dialysis that uses the patient's own peritoneal membrane to filter waste products from the blood. Home hemodialysis is a type of dialysis that uses a dialysis machine to filter waste products from the blood. Both peritoneal dialysis and home hemodialysis require training and support from a healthcare professional, but they can offer patients a greater degree of flexibility and control over their treatments. ## **Hemodialysis and Peritoneal Dialysis Market Segment Insights:** ### **Hemodialysis and Peritoneal Dialysis Market Procedure Insights** Hemodialysis dominated the market in 2023 with a revenue share of nearly 80%, owing to its widespread adoption in hospitals and clinics as a treatment option for patients with end-stage renal disease (ESRD). Peritoneal dialysis, on the other hand, held a smaller market share due to its limited applicability and preference for home-based treatment. Hemodialysis involves the removal of waste products and excess fluids from the blood by passing it through a dialyzer, a special filter. This procedure is typically performed in a hospital or dialysis center, and it requires a trained healthcare professional to operate the machine. Hemodialysis is a life-sustaining treatment for patients with ESRD, and it can significantly improve their quality of life. Peritoneal dialysis, on the other hand, utilizes the patient's own peritoneal membrane as a natural filter to remove waste products and excess fluids from the blood. This procedure can be performed at home, offering greater convenience and flexibility for patients. However, it is less efficient than hemodialysis and requires a longer duration of treatment. Peritoneal dialysis is often preferred by patients who are not suitable for hemodialysis, such as those with severe cardiovascular disease or vascular access issues. The growth of the Hemodialysis and Peritoneal Dialysis Market is primarily driven by the increasing prevalence of chronic kidney disease (CKD) and ESRD worldwide. The rising incidence of diabetes, hypertension, and obesity are major contributing factors to the growing number of CKD patients, which in turn is fueling the demand for dialysis treatments. Additionally, advancements in dialysis technology and the development of new and more efficient dialyzers are expected to further drive market growth. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ### **Hemodialysis and Peritoneal Dialysis Market Product Type Insights** The Hemodialysis and Peritoneal Dialysis Market is a market that is segmented by product type and geography. By product type, the market is divided into dialysis machines, dialysis consumables, and dialysis accessories. Among these segments, the dialysis machines segment is expected to account for the largest market size in 2023. The growth of this segment can be attributed to the growing prevalence of chronic kidney disease and the increasing demand for hemodialysis treatment across the globe. The dialysis consumables segment is expected to grow at a considerable rate due to the high number of hemodialysis procedures and the need for their regular replacement. The dialysis accessories segment is projected to grow at a steady rate due to the increased demand for these accessories, such as dialysis chairs, water treatment systems, and monitoring devices, among others. ### **Hemodialysis and Peritoneal Dialysis Market Application Insights** The Hemodialysis and Peritoneal Dialysis Market is segmented based on application into End-Stage Renal Disease, Acute Renal Failure, Chronic Kidney Disease. The End-Stage Renal Disease segment is expected to account for the largest share of the market in 2023, owing to the increasing prevalence of chronic kidney disease and the rising demand for dialysis services. The Acute Renal Failure segment is expected to witness the fastest growth during the forecast period due to the growing number of patients with acute kidney injuries and the increasing adoption of peritoneal dialysis for acute renal failure. The Chronic Kidney Disease segment is expected to account for a significant share of the market in 2023 and is expected to grow at a steady pace during the forecast period. ### **Hemodialysis and Peritoneal Dialysis Market End User Insights** The Hemodialysis and Peritoneal Dialysis Market is segmented by end user into hospitals, dialysis centers, and home healthcare. Hospitals are the largest end user of Hemodialysis and Peritoneal Dialysis products and services, accounting for over 60% of the market revenue in 2023. Dialysis centers are the second largest end user, accounting for over 25% of the market revenue. Home healthcare is the smallest end user, accounting for less than 15% of the market revenue. The growth of the home healthcare segment is expected to be driven by the increasing demand for home-based dialysis treatments. ### **Hemodialysis and Peritoneal Dialysis Market Modality Insights** The Hemodialysis and Peritoneal Dialysis Market is segmented by modality into in-center hemodialysis, home hemodialysis, and continuous renal replacement therapy (CRRT). In 2023, the in-center hemodialysis segment accounted for the largest share of the market, with a revenue of USD 9.2 billion. This is because in-center hemodialysis is the most common type of dialysis, and it is typically performed in a hospital or clinic setting. The home hemodialysis segment is expected to grow at a faster rate than the in-center hemodialysis segment over the forecast period, due to the increasing demand for home-based care. The CRRT segment is expected to grow at a steady rate over the forecast period due to the increasing incidence of acute kidney injury. ### **Hemodialysis and Peritoneal Dialysis Market Regional Insights** The Hemodialysis and Peritoneal Dialysis Market is segmented into regions such as North America, Europe, APAC, South America, and MEA. In 2023, North America held the largest market share of 38.5% and is expected to continue its dominance throughout the forecast period. The significant prevalence of kidney diseases in the region, coupled with the presence of well-established healthcare infrastructure and high disposable income, contribute to the growth of the market in North America. Europe holds the second-largest market share, driven by the rising geriatric population and increasing cases of chronic kidney diseases. APAC is projected to witness the highest growth rate during the forecast period, owing to the rising healthcare expenditure, improving economies, and growing awareness about kidney diseases in developing countries such as China and India. South America and MEA are expected to experience moderate growth due to limited healthcare infrastructure and low awareness about kidney diseases in these regions. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review **Hemodialysis and Peritoneal Dialysis Market Key Players and Competitive Insights:** Key players in the Hemodialysis and Peritoneal Dialysis Market are investing heavily to maintain their market position and expand their market share. Major players in this market include companies such as Fresenius Medical Care, Baxter International, DaVita Healthcare Partners, Inc., Diaverum Deutschland, etc. Market leaders in general are focusing on developing new products and technologies, increasing geographic coverage, and expanding their product portfolio and distribution channels through acquisitions of smaller companies. The Hemodialysis and Peritoneal Dialysis Market is a relatively mature one with many large, established players. Moreover, the market is highly competitive due to the presence of many companies, most of which operate on a regional scale. The competitive landscape is expected to remain fragmented for many years to come. The leading companies in the Hemodialysis and Peritoneal Dialysis Market have strong, established positions in several different geographical areas, and their products and services are diverse. For instance, Fresenius Medical Care is a Hemodialysis and Peritoneal Dialysis Market company which has a wide range of products and services for the treatment of chronic kidney disease. The company has a strong global presence, and it is investing heavily in research and development to continuously improve its product and service offerings. Fresenius Medical Care is also expanding its geographic coverage and entering new markets. Another player in the Hemodialysis and Peritoneal Dialysis Market is Baxter International, which manufactures a wide range of products and services for the treatment of kidney disease. The company has a strong presence in the United States and Europe, and it is also entering new, emerging markets. Baxter International is also investing heavily in the development of new products and technologies, such as its new home hemodialysis system. Using artificial intelligence and machine learning, they also seek to transform the operation of their manufacturing networks and increase the efficiency and cost-effectiveness of their manufacturing processes. **Key Companies in the Hemodialysis and Peritoneal Dialysis Market Include:** **Hemodialysis and Peritoneal Dialysis Market Developments** _Growth is attributed to the increasing prevalence of chronic kidney disease, rising geriatric population, and technological advancements in dialysis treatments. Key market players include Fresenius Medical Care, Baxter International, and Nipro Corporation._ _Recent news includes Baxter's launch of the NxStage System One, a portable hemodialysis machine, and Fresenius Medical Care's acquisition of NxStage Medical, expanding its home dialysis offerings._ _The market is expected to witness increased adoption of peritoneal dialysis and home hemodialysis, driven by patient convenience and cost-effectiveness._ ## **Hemodialysis and Peritoneal Dialysis Market Segmentation Insights** ### **Hemodialysis and Peritoneal Dialysis Market Procedure Outlook** ### **Hemodialysis and Peritoneal Dialysis Market Product Type Outlook** ### **Hemodialysis and Peritoneal Dialysis Market Application Outlook** ### **Hemodialysis and Peritoneal Dialysis Market End User Outlook** ### **Hemodialysis and Peritoneal Dialysis Market Modality Outlook** ### **Hemodialysis and Peritoneal Dialysis Market Regional Outlook** ## Market Drivers ### Increasing Prevalence of Kidney Diseases The rising incidence of chronic kidney diseases (CKD) is a primary driver for the Hemodialysis and Peritoneal Dialysis Market. According to recent statistics, approximately 10% of the population worldwide is affected by CKD, leading to a growing demand for dialysis treatments. This trend is particularly pronounced in aging populations, where the prevalence of kidney-related ailments tends to escalate. As healthcare systems strive to manage this increasing burden, investments in dialysis infrastructure and technology are likely to expand. Furthermore, the need for effective renal replacement therapies is expected to propel the market forward, as healthcare providers seek to offer comprehensive solutions for patients suffering from kidney dysfunction. ### Shift Towards Home-Based Dialysis Solutions The shift towards home-based dialysis solutions is reshaping the Hemodialysis and Peritoneal Dialysis Market. Patients increasingly prefer the convenience and flexibility of receiving treatment in their own homes, which has led to a rise in the adoption of peritoneal dialysis. Market analysis reveals that home dialysis therapies are expected to account for a larger share of the overall dialysis market, driven by patient preferences and advancements in technology. This transition not only enhances the quality of life for patients but also reduces the burden on healthcare facilities. As a result, healthcare providers are likely to expand their offerings of home dialysis options, further propelling market growth. ### Rising Awareness and Education on Kidney Health Rising awareness and education regarding kidney health are pivotal in driving the Hemodialysis and Peritoneal Dialysis Market. Public health campaigns and initiatives aimed at educating individuals about the risks of kidney diseases are fostering early detection and treatment. Increased awareness leads to more individuals seeking medical advice and, consequently, a higher demand for dialysis services. Furthermore, healthcare professionals are emphasizing the importance of regular screenings and lifestyle modifications to prevent kidney-related issues. This proactive approach is likely to contribute to a growing patient population requiring dialysis, thereby stimulating market growth in the coming years. ### Technological Innovations in Dialysis Equipment Technological advancements in dialysis equipment are significantly influencing the Hemodialysis and Peritoneal Dialysis Market. Innovations such as portable dialysis machines and automated peritoneal dialysis systems are enhancing patient convenience and treatment efficacy. The introduction of smart technology, including remote monitoring and data analytics, allows healthcare providers to optimize treatment plans and improve patient outcomes. Market data indicates that the demand for advanced dialysis equipment is projected to grow at a compound annual growth rate (CAGR) of over 6% in the coming years. This trend suggests that manufacturers are likely to invest heavily in research and development to meet the evolving needs of patients and healthcare providers. ### Government Initiatives and Support for Dialysis Services Government initiatives and support for dialysis services play a crucial role in shaping the Hemodialysis and Peritoneal Dialysis Market. Many governments are implementing policies to improve access to dialysis treatments, particularly in underserved regions. Financial assistance programs and subsidies for dialysis patients are becoming more common, which enhances affordability and accessibility. Additionally, regulatory frameworks are evolving to ensure the quality and safety of dialysis services. Market data suggests that these initiatives are likely to lead to an increase in the number of dialysis centers and services available, ultimately benefiting patients and driving market expansion. ## Future Outlook The Hemodialysis and Peritoneal Dialysis Market is projected to grow at a 5.92% CAGR from 2025 to 2035, driven by technological advancements, increasing patient populations, and rising healthcare expenditures. **New opportunities:** - Development of portable dialysis devices for home use - - Integration of telehealth services for remote patient monitoring - Expansion of partnerships with healthcare providers for bundled payment models By 2035, the market is expected to be robust, driven by innovation and strategic collaborations. ## Segment Insights ### By Procedure: Hemodialysis (Largest) vs. Peritoneal Dialysis (Fastest-Growing) In the Hemodialysis and Peritoneal Dialysis Market, Hemodialysis holds the largest share, primarily due to its long-established efficacy and reliability in treating patients with kidney failure. This procedure remains the preferred choice for a significant number of healthcare professionals owing to its extensive clinical experience and infrastructure support. Peritoneal Dialysis, while capturing a smaller share, is gaining traction as it offers unique benefits like increased flexibility and better quality of life for patients at home. As such, these two procedures represent diverse approaches in renal replacement therapy. Hemodialysis (Dominant) vs. Peritoneal Dialysis (Emerging) Hemodialysis is characterized by its use of a dialysis machine, which filters waste, salts, and fluids from the bloodstream, typically conducted in a clinic or hospital setting. It remains dominant due to its proven success and safety records. Conversely, Peritoneal Dialysis is emerging as a vital alternative, particularly for patients seeking home-based therapies. Utilizing the peritoneum as a membrane for filtration, it facilitates greater autonomy in self-care. The growing preference for at-home treatment options, advances in technology, and increasing awareness of patient-centered care are propelling Peritoneal Dialysis towards a more significant position in the market. ### By Product Type: Dialysis Machines (Largest) vs. Dialysis Consumables (Fastest-Growing) In the Hemodialysis and Peritoneal Dialysis Market, the product type segment showcases a significant distribution among Dialysis Machines, Dialysis Consumables, and Dialysis Accessories. Dialysis Machines hold the largest share, attributed to their essential role in treatment procedures and technological advancements that enhance patient care. Conversely, Dialysis Consumables and Accessories, while smaller in share, are critical for efficient treatment delivery and are witnessing rapid growth as they become integral parts of monitoring and administration in dialysis therapies. Dialysis Machines (Dominant) vs. Dialysis Accessories (Emerging) Dialysis Machines are considered the dominant product in the Hemodialysis and Peritoneal Dialysis Market. These machines are indispensable for patient treatment, featuring advanced technologies that improve efficiency and patient outcomes. In contrast, Dialysis Accessories are emerging with innovative technologies that support the main machines by enhancing usability and patient comfort. While they have historically been secondary to machines, their evolving features are increasingly important for holistic treatment approaches, positioning them as key contributors to patient management and treatment efficacy in dialysis care. ### By Application: End-Stage Renal Disease (Largest) vs. Chronic Kidney Disease (Fastest-Growing) In the Hemodialysis and Peritoneal Dialysis market, the application segments are primarily distributed among End-Stage Renal Disease (ESRD), Acute Renal Failure (ARF), and Chronic Kidney Disease (CKD). Notably, ESRD constitutes the largest share, owing to its high prevalence and critical need for dialysis. Acute Renal Failure, while significant, occupies a smaller market share compared to the other applications, though it remains essential for emergency care situations. CKD, on the other hand, is emerging rapidly, reflecting the increasing incidence of this condition globally. End-Stage Renal Disease: Dominant vs. Chronic Kidney Disease: Emerging End-Stage Renal Disease (ESRD) stands as the dominant application in the Hemodialysis and Peritoneal Dialysis market due to its critical and chronic nature. Patients with ESRD require ongoing dialysis support, which solidifies the relevance of hemodialysis and peritoneal dialysis techniques in treatment protocols. Conversely, Chronic Kidney Disease (CKD) is categorized as an emerging segment, driven by rising risk factors such as diabetes and hypertension. This condition often leads to ESRD, thus increasing demand for dialysis. The swift growth of CKD awareness and treatment adoption positions it as a pivotal area for market innovation and expansion, revealing a shift in healthcare strategies to address renal health earlier in the disease continuum. ### By End User: Dialysis Centers (Largest) vs. Home Healthcare (Fastest-Growing) The 'End User' segment of the Hemodialysis and Peritoneal Dialysis Market is primarily composed of Hospitals, Dialysis Centers, and Home Healthcare. Among these, Dialysis Centers hold the largest market share due to their specialized services and dedicated resources for dialysis treatment. Hospitals also play a significant role, providing both acute and chronic care for patients requiring dialysis. Home Healthcare, while currently smaller in market share, is rapidly gaining ground as more patients prefer the convenience of receiving treatment in their own homes. Dialysis Centers (Dominant) vs. Home Healthcare (Emerging) Dialysis Centers are the dominant force in the Hemodialysis and Peritoneal Dialysis Market, characterized by their comprehensive facilities and availability of specialized healthcare professionals. They offer a range of services tailored to patients undergoing dialysis, ensuring optimal care and support. On the other hand, Home Healthcare is emerging as a valuable alternative, driven by increasing patient autonomy and preference for home-based treatments. This segment appeals to patients looking for flexibility and comfort, with advancements in technology enhancing the effectiveness and safety of home dialysis. As healthcare evolves, both segments are expected to coexist, catering to diverse patient needs. ### By Modality: In-Center Hemodialysis (Largest) vs. Home Hemodialysis (Fastest-Growing) In the Hemodialysis and Peritoneal Dialysis Market, In-Center Hemodialysis is the most significant segment, holding the largest market share due to its established infrastructure and availability in healthcare facilities. This modality caters to a broad patient demographic and is preferred for its professional supervision, ensuring effective treatment. In contrast, Home Hemodialysis is quickly gaining traction, driven by an increasing patient preference for convenience and flexibility. This shift reflects a marked change in patient lifestyles, preferences, and the growing awareness of self-management options. In-Center Hemodialysis (Dominant) vs. Home Hemodialysis (Emerging) In-Center Hemodialysis remains the dominant modality within the market, primarily because of its longstanding presence and the assurance of skilled medical staff overseeing treatment. Patients benefit from regular monitoring and immediate access to emergency care, enhancing safety. However, Home Hemodialysis is emerging as a favorable alternative, particularly among younger patients seeking autonomy in managing their health. Increased focus on patient-centered care, technological advancements in equipment, and supportive home care services are substantial factors contributing to its rapid growth. As more patients adapt to a home setting for their dialysis needs, this sector is poised for significant expansion in the coming years. ## Regional Market Share Analysis The Hemodialysis and Peritoneal Dialysis Market is segmented into regions such as North America, Europe, APAC, South America, and MEA. In 2023, North America held the largest market share of 38.5% and is expected to continue its dominance throughout the forecast period. The significant prevalence of kidney diseases in the region, coupled with the presence of well-established healthcare infrastructure and high disposable income, contribute to the growth of the market in North America. Europe holds the second-largest market share, driven by the rising geriatric population and increasing cases of chronic kidney diseases. APAC is projected to witness the highest growth rate during the forecast period, owing to the rising healthcare expenditure, improving economies, and growing awareness about kidney diseases in developing countries such as China and India. South America and MEA are expected to experience moderate growth due to limited healthcare infrastructure and low awareness about kidney diseases in these regions. ## Competitive Benchmarking Key players in the Hemodialysis and Peritoneal Dialysis Market are investing heavily to maintain their market position and expand their market share. Major players in this market include companies such as Fresenius Medical Care, Baxter International, DaVita Healthcare Partners, Inc., Diaverum Deutschland, etc.Market leaders in general are focusing on developing new products and technologies, increasing geographic coverage, and expanding their product portfolio and distribution channels through acquisitions of smaller companies.The Hemodialysis and Peritoneal Dialysis Market is a relatively mature one with many large, established players. Moreover, the market is highly competitive due to the presence of many companies, most of which operate on a regional scale.The competitive landscape is expected to remain fragmented for many years to come. The leading companies in the Hemodialysis and Peritoneal Dialysis Market have strong, established positions in several different geographical areas, and their products and services are diverse.For instance, Fresenius Medical Care is a Hemodialysis and Peritoneal Dialysis Market company which has a wide range of products and services for the treatment of chronic kidney disease. The company has a strong global presence, and it is investing heavily in research and development to continuously improve its product and service offerings.Fresenius Medical Care is also expanding its geographic coverage and entering new markets. Another player in the Hemodialysis and Peritoneal Dialysis Market is Baxter International, which manufactures a wide range of products and services for the treatment of kidney disease.The company has a strong presence in the United States and Europe, and it is also entering new, emerging markets. Baxter International is also investing heavily in the development of new products and technologies, such as its new home hemodialysis system.Using artificial intelligence and machine learning, they also seek to transform the operation of their manufacturing networks and increase the efficiency and cost-effectiveness of their manufacturing processes. ## Recent News & Developments _Growth is attributed to the increasing prevalence of chronic kidney disease, rising geriatric population, and technological advancements in dialysis treatments. Key market players include Fresenius Medical Care, Baxter International, and Nipro Corporation._ _Recent news includes Baxter's launch of the NxStage System One, a portable hemodialysis machine, and Fresenius Medical Care's acquisition of NxStage Medical, expanding its home dialysis offerings._ _The market is expected to witness increased adoption of peritoneal dialysis and home hemodialysis, driven by patient convenience and cost-effectiveness._ ## Report Scope | MARKET SIZE 2024 | 113.13(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 119.83(USD Billion) | | MARKET SIZE 2035 | 212.98(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.92% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Fresenius Medical Care (DE), DaVita Inc. (US), Baxter International Inc. (US), Nipro Corporation (JP), Medtronic plc (IE), Asahi Kasei Corporation (JP), Kawasumi Laboratories, Inc. (JP), Dialysis Clinic, Inc. (US), Renal Care Group (US) | | Segments Covered | Procedure, Product Type, Application, End User, Modality, Regional | | Key Market Opportunities | Advancements in home-based dialysis technologies enhance patient autonomy in the Hemodialysis and Peritoneal Dialysis Market. | | Key Market Dynamics | Technological advancements and regulatory changes are reshaping the competitive landscape of the Hemodialysis and Peritoneal Dialysis Market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the current market valuation of the Hemodialysis and Peritoneal Dialysis Market?** A: As of 2024, the market valuation stands at 113.13 USD Billion. **Q: What is the projected market size for the Hemodialysis and Peritoneal Dialysis Market by 2035?** A: The market is expected to reach a valuation of 212.98 USD Billion by 2035. **Q: What is the expected CAGR for the Hemodialysis and Peritoneal Dialysis Market during the forecast period 2025 - 2035?** A: The market is anticipated to grow at a CAGR of 5.92% from 2025 to 2035. **Q: Which companies are considered key players in the Hemodialysis and Peritoneal Dialysis Market?** A: Key players include Fresenius Medical Care, DaVita Inc., Baxter International Inc., and Nipro Corporation. **Q: What are the projected revenues for Hemodialysis and Peritoneal Dialysis procedures by 2035?** A: By 2035, Hemodialysis is projected to generate revenues between 70.0 and 135.0 USD Billion, while Peritoneal Dialysis is expected to reach 43.13 to 77.98 USD Billion. **Q: How do the revenues from dialysis machines compare to dialysis consumables by 2035?** A: In 2035, revenues from dialysis machines are projected to range from 30.0 to 60.0 USD Billion, whereas dialysis consumables are expected to generate between 50.0 and 100.0 USD Billion. **Q: What is the expected revenue range for the application of End-Stage Renal Disease by 2035?** A: The revenue for End-Stage Renal Disease applications is projected to be between 45.0 and 85.0 USD Billion by 2035. **Q: Which end-user segment is expected to generate the highest revenue by 2035?** A: Hospitals are anticipated to generate the highest revenue, projected between 45.0 and 85.0 USD Billion by 2035. **Q: What is the revenue outlook for In-Center Hemodialysis by 2035?** A: In-Center Hemodialysis is expected to generate revenues ranging from 60.0 to 115.0 USD Billion by 2035. **Q: How does the market for Home Healthcare compare to other end-user segments by 2035?** A: By 2035, Home Healthcare is projected to generate revenues between 28.13 and 47.98 USD Billion, which is lower than hospitals and dialysis centers. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/hemodialysis-peritoneal-dialysis-market-24365*